ロード中...
(89)Zr-ImmunoPET Companion Diagnostics and their Impact in Clinical Drug Development
Therapeutic monoclonal antibodies (mAbs) have been used in cancer treatment for 30 years, with around 24 mAb and mAb:drug conjugates approved by the FDA to date. Despite their specificity, efficacy has remained limited, which, in part, derails nascent initiatives towards precision medicine. An image...
保存先:
| 出版年: | J Labelled Comp Radiopharm |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6050145/ https://ncbi.nlm.nih.gov/pubmed/29341222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jlcr.3605 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|